Side effects-of-thyroid-compound-2010

444 views

Published on

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Side effects-of-thyroid-compound-2010

  1. 1. Too Much Thyroxine Medication Symptoms 001 Side Effects Of Synthroid Headaches Food and Drugs Association ApprovedLevothyroxine Side Effects For DogsThyroxine Side Effects In The UkPharmaceutical industry; Factor productivity; Returns to scale HirokuniBeppu, Japans loss of leadership role in access to drug data, TheLancet, Volume 353, Issue 9169, 12 June 1999, Page 1992, ISSN0140-6736, 10.1016/S0140-6736(99)00184-1. Bryan G. Reuben,Chapter 45 - The Consumption and Production of Pharmaceuticals, In:Camille Georges Wermuth, Editor(s), The Practice of MedicinalChemistry (Third Edition), Academic Press, New York, 2008, Pages894-921, ISBN 9780123741943,10.1016/B978-0-12-374194-3.00045-7. Bruce Goldstein, Chapter 22 - 1/6
  2. 2. Too Much Thyroxine Medication Symptoms 001 Side Effects Of Synthroid Headaches Food and Drugs Association ApprovedOverview of technology development, In: John I. Gallin and Frederick P.Ognibene, Editor(s), Principles and Practice of Clinical Research(Second Edition), Academic Press, Burlington, 2007, Pages 291-314,ISBN 9780123694409, 10.1016/B978-012369440-9/50026-8. Abstract:The changes during the last 20 years in the dynamics of scientificprogress generally, and in the biomedical arena in particular, havebeen as dramatic as the changes wrought upon a landscape by a riveraltering course, flooding some regions and carving others. Inexorably,the ground that had been solid crumbles, and new shores emerge. Forthose who have established the foundations of their research careersin the realm of pure academia, the new landscape lacks many of thefamiliar landmarks and paths. Although many people find suchchanges disturbing, confusing, or simply aggravating, the mostsuccessful researchers will have to learn to navigate the new terrain.Bryan G. Reuben, 43 - The Consumption and Production ofPharmaceuticals, In: Camille G. Wermuth, Editor(s), The Practice ofMedicinal Chemistry (Second Edition), Academic Press, London, 2003,Pages 723-749, ISBN 9780127444819,10.1016/B978-012744481-9/50047-7. Guillermo Di Girolamo, GuillermoA. Keller, Antonio R. de los Santos, Daniel Schere, Claudio D. Gonzalez,Bioequivalence of two levothyroxine tablet formulations without andwith mathematical adjustment for basal thyroxine levels in healthyArgentinian volunteers: A single-dose, randomized, open-label,crossover study, Clinical Therapeutics, Volume 30, Issue 11, November2008, Pages 2015-2023, ISSN 0149-2918,10.1016/j.clinthera.2008.11.005. Abstract: Background: Levothyroxinehas a narrow therapeutic index; therefore, precise and accurateassessment of the bioequivalence of different levothyroxine products iscritical. Bioavailability estimates of levothyroxine formulations mightbe affected by baseline concentrations of the hormone. Objectives: Theaim of this study was to assess the bioequivalence of 100 µg of a test(T4 Montpellier® 100, Química Montpellier S.A., Buenos Aires,Argentina) and reference (Synthroid®, Abbott Laboratories, AbbottPark, Illinois) formulation of levothyroxine. We also compared 2methods of levothyroxine measurements: without and with baselinecorrection for endogenous levothyroxine. Methods: This randomized,open-label, 2-sequence, crossover study with a 65-day washout periodwas carried out in healthy, white, euthyroid volunteers following asingle dose of sodium levothyroxine 600 µg. Blood samples were 2/6
  3. 3. Too Much Thyroxine Medication Symptoms 001 Side Effects Of Synthroid Headaches Food and Drugs Association Approvedcollected at 30 and 15 minutes prior to administration, and 0(baseline), 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12, 24, and 48 hours todetermine thyroxine; serum thyrotropin (TSH) concentrations weredetermined 30 minutes before administration and 48 hours afteradministration. Serum concentrations of thyroxine were determinedthrough radioimmunoassay and serum TSH concentrations weredetermined by a validated 2-site immunoradiometric assay. Theformulations are considered to be equivalent if the 90% CI ratios forCmax and AUC0-last are within 80% to 125%, per the US Food andDrug Administration (FDA). Adverse event monitoring was performedthroughout the study by assessing clinical parameters (eg, bloodpressure, electrocardiogram) and patient reports. Results: A total of 24volunteers (16 male, 8 female; mean [SD] age, 30.2 [4.6] years [range,21-40 years]; mean [SD] weight, 71.71 [7.52] kg [range, 58-83 kg])were included in the study. Without adjustment for baseline levels ofendogenous levothyroxine, geometric mean Cmax for the test andreference formulations were 8.92 and 9.39 µg/dL, respectively;AUC0-last values were 368.40 and 383.37 µg/mL · h-1. The 90% CI ofthe geometric mean for the percent ratios (test: reference) of Cmaxand AUC0-last were 95.1% (90% CI, 91.9–98.3) and 96.1% (90% CI,94.0–98.2), respectively. With adjustment for baseline levels ofendogenous levothyroxine, the geometric mean Cmax for the test andreference formulations were 3.16 and 3.39 µg/dL, respectively;AUC0-last values were 88.33 and 95.60 µg/mL · h-1. Despiteperforming the adjustment, the 90% CI of the geometric mean forCmax and AUC0-last test:reference ratios were 93.1% (90% CI,84.9–102.2) and 92.4% (90% CI, 85.2–100.2), respectively. Nosignificant between-group differences were found with regard topharmacokinetic parameters. No adverse events were observed orreported. Conclusion: The results of this study suggest that the testformulation was bioequivalent to the reference formulation oflevothyroxine in these healthy volunteers, according to the US FDAdefinition of bioequivalence. This was supported by the analysis ofconcentration-time profiles without and with correction for basalendogenous levothyroxine.Side Effect Of Synthroid Anxietylevothyroxine; thyroxine; bioequivalence; pharmacokinetics; 3/6
  4. 4. Too Much Thyroxine Medication Symptoms 001 Side Effects Of Synthroid Headaches Food and Drugs Association Approvedmethodology; endogenous Bruce Goldstein, Chapter 20 - Overview ofTechnology Development, Principles and Practice of Clinical Research,Academic Press, San Diego, 2002, Pages 307-328, ISBN9780122740657, 10.1016/B978-012274065-7/50022-8. MichaelBryer-Ash, EVALUATION OF THE PATIENT WITH A SUSPECTED THYROIDDISORDER, Obstetrics and Gynecology Clinics of North America,Volume 28, Issue 2, 1 June 2001, Pages 421-438, ISSN 0889-8545,10.1016/S0889-8545(05)70209-6. Abstract: Thyroid disorders arehighly prevalent in both undeveloped and industrialized regions of theworld.44 In general, these disorders are more common in women thanmen and increase in prevalence with age. In particular, the onset ofautoimmune thyroid disease is relatively uncommon in the intervalbetween the neonatal period and mid-adolescence.22 Thyroid functiontests are among the most common investigations ordered in clinicallaboratories. Although these tests are relatively inexpensiveindividually, they account for a disproportionately large amount ofhealth care expenditure for diagnostic testing.43 The principalcategories of thyroid disorders most commonly encountered bypractitioners who are not in endocrine specialty practice aregeneralized goiter, thyroid nodules, clinical hyperthyroidism orhypothyroidism, and abnormal thyroid function tests in clinicallyeuthyroid individuals. This review is designed to provide theobstetrician-gynecologist with a practical guide to the initialinvestigation and diagnosis of the common types of incidentallydiscovered thyroid problems as they present. Therefore, disorders suchas postpartum thyroiditis, the management of thyroid dysfunctionduring pregnancy, and the relationship between thyroid dysfunctionand infertility, which are considered central to obstetric andgynecologic practice, are not reviewed in detail. Similarly, definitivemanagement and follow-up of most thyroid disorders generally requirethe involvement of the patient′s family physician, internist, orendocrinologist with or without the support of a general or head andneck surgeon and are not comprehensively discussed here. Benjamin J.Westenberger, Christopher D. Ellison, Andrew S. Fussner, SusanJenney, Richard E. Kolinski, Terra G. Lipe, Robbe C. Lyon, Terry W.Moore, Larry K. Revelle, Anjanette P. Smith, John A. Spencer, KimberlyD. Story, Duckhee Y. Toler, Anna M. Wokovich, Lucinda F. Buhse,Quality assessment of internet pharmaceutical products usingtraditional and non-traditional analytical techniques, International 4/6
  5. 5. Too Much Thyroxine Medication Symptoms 001 Side Effects Of Synthroid Headaches Food and Drugs Association ApprovedJournal of Pharmaceutics, Volume 306, Issues 1-2, 8 December 2005,Pages 56-70, ISSN 0378-5173, 10.1016/j.ijpharm.2005.08.027.Abstract: This work investigated the use of non-traditional analyticalmethods to evaluate the quality of a variety of pharmaceuticalproducts purchased via internet sites from foreign sources andcompared the results with those obtained from conventional qualityassurance methods. Traditional analytical techniques employing HPLCfor potency, content uniformity, chromatographic purity and drugrelease profiles were used to evaluate the quality of five selected drugproducts (fluoxetine hydrochloride, levothyroxine sodium, metforminhydrochloride, phenytoin sodium, and warfarin sodium). Non-traditionaltechniques, such as near infrared spectroscopy (NIR), NIR imaging andthermogravimetric analysis (TGA), were employed to verify the resultsand investigate their potential as alternative testing methods. Two of20 samples failed USP monographs for quality attributes. Theadditional analytical methods found 11 of 20 samples had differentformulations when compared to the U.S. product. Seven of the 20samples arrived in questionable containers, and 19 of 20 hadincomplete labeling. Only 1 of the 20 samples had final packagingsimilar to the U.S. products. The non-traditional techniquescomplemented the traditional techniques used and highlightedadditional quality issues for the products tested. For example, thesemethods detected suspect manufacturing issues (such as blending),which were not evident from traditional testing alone. 5/6
  6. 6. Too Much Thyroxine Medication Symptoms 001 Side Effects Of Synthroid Headaches Food and Drugs Association Approved 6/6Powered by TCPDF (www.tcpdf.org)

×